Abstract
The human body is constantly under assault by potential microbial pathogens. In addition to the enormous numbers of micro-organisms that we ingest, inhale, aspirate, and come in direct contact with on a daily basis, the average human has 1014 (one hundred trillion) micro-organisms in the alimentary tract and on epithelial surfaces throughout the body (1). Transient bacteremia is a frequent event from oral microbial flora or skin flora following minor trauma to these areas (e.g. 25% incidence of bacteremia with brushing teeth) (2). A multitude of fungal spores are inhaled on a daily basis and humans are repeatedly exposed to potentially pathogenic respiratory viruses in the environment. Our very existence is absolutely dependent upon an ever vigilant and efficient antimicrobial defense system. In this introductory chapter, we will review the fundamental elements of the host defense system and describe the basic strategies employed against bacteria, viruses, and fungi.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Savage DC. Microbial ecology of the gastro-intestinal tract. Ann Rev Med. 1997; 31:107–133.
Everett FD, Hirshmann JV. Transient bacteremia and endocarditis prophylaxis: a review. Medicine. 1977; 56:61–77.
Casadevall A, Pirofskil-A. Host-pathogen interactions: redefining basic concepts of virulence and pathogenicity. Infect Immun 1999; 67:3703–3713.
Janeway CA, Jr., The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today. 1992; 13:11–16.
Opal SM. The phylogenetic relationships between the inflammatory networks. Crit Care Med. 2000; 28:577–582.
Lekstrom-Himes JA, Gallin JI. Immunodeficiency diseases caused by defects in phagocytes. N Engl J Med. 2000; 343:1703–1714.
Malech HC, Nauseef WM. Primary inherited defects in neutrophil function: etiology and treatment. Semin Hematol 1997; 34:279–290.
Doan CA. The neutropenic state: its significance and therapeutics rationale. JAMA. 1932;99:194–202.
Simms HH, Frank MM, Quinn TC, Holland S, Gaither TA. Studies on phagocytosis in patients with acute bacterial infections. J Clin Invest. 1989; 83:252–260.
Finlay-Jones JJ, Hart PH, Spencer LK, Nulsen MF, Kenny PA, McDonald PJ. Bacterial killing in vitro by abscess-derived neutrophils. J Med Microbiol. 1991; 34:73–81.
Alexiewicz JM, Kumar D, Smorgorzewski M, Klin M, Massry SG. Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function. Ann Intern Med. 1995; 123:919–924.
Medzhitov R, Preston-Hurlburt P, Janeway, CA. A human homologue of the Drosphila toll protein signals activation of adaptive immunity. Nature. 1997, 388:394–397.
Hoshino K., et al. Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide evidence for TLR4 as the LPS gene product. J. Immunol. 1999; 162:3749–3752.
Rock FL, Hardiman G, Timans JE, Kastelein RA, Bazan JF. A family of human receptors structurally related to Drosphila Toll. Proc Natl Acad Sci USA. 1998, 95:588–593.
Yoshimura A, et al. Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol. 1999; 163:1–5.
Underhill DM, et al. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature. 1999, 401:811–815.
Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S. A toll-like receptor recognizes bacterial DNA. Nature. 2000, 408:740–744.
Lipford GB, Heeg K, Wagner H. Bacterial DNA as immune cell activator. Trends Microbiol. 1998; 6:496–500.
Brightbill HD et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science. 1999; 285:732–736.
Aliprantis AO, et al. Cell activations and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science. 1999; 285:736–739.
Coxon A, Tang T, Mayadas TN. Cytokine-activated endothelial cells delay neutrophil apoptosis in vitro and in vivo. A role for granulocyte-macrophage colony stimulating factor. J Exp Med. 1999; 190:923–934
Dulkanchainun TS, Goss JA, Imagawa DK, Shaw GD, Anselmo DM, Kaldas F, Wang T, Shao D, Ashley A, Busuttil A, Kato H, Murry NGB, Kupiec-Weglinski JW, Busuttil RW. Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1. Ann Surg. 1998; 227:832–840.
Ley K, Bullard DC, Arbones ML, Bosse R, Vestweber D, Tedder TF, Beaudet AL. Sequential contribution of L- and P-selectin to leukocyte rolling in vivo. J Exp Med. 1995; 181:669–675.
Jung U, Ley K. Mice lacking two or all three selectins demonstrate overlapping and distinct functions for each selectin1. J Immunol. 1999; 6755–6762.
Munoz FM, Hawkins EP, Bullard DC, Beaudet AL, Kaplan SL. Host defense against systemic infection with Streptococcus pneumoniae is impaired in E-, P-, and E-/P-selectin-deficient mice. J Clin Invest. 1997; 100:2009–2106.
Yee AMF, Phan HM, Zuniga R, Salmon JE, Musher DM. Association between Fcγ RIIa-R131 allotype and bacteremic pneumococcal pneumonia. Clin Infect Dis. 2000; 30:25–28.
Galán JE, Collmer A. Type III secretion machines: bacterial devises for protein delivery into host cells. Science. 1999; 284:1322–1328.
Kaufmann SHE. Immunity to intracellular microbial pathogens. Immunol Today. 1995; 16:338–342.
Zychlinsky A, Prévost MC, Sansonetti PJ. Shigella flexneri induces apoptosis in infected macrophages. Nature. 1992; 358:167–169.
Lehrer RI, Ganz T, Selsted ME. Defensins: Natural peptide_antibiotics from neutrophils. ASM News. 1990; 56:315–318.
Finlay BB, Falco S. Common themes in microbial pathogenecity revisited. Microbiol Mol Biol Rev. 1997; 61:136–169.
Kanangat S, Meduri GU, Tolley EA, et al. Effects of cytokines and endotoxin on the intracellular growth of bacteria. Infect Immun. 1999; 67:2834–2840.
Clark RA, Malech HL, Gallin JL, et al. Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system. N Engl J Med. 1989; 321:647–652.
Winkelstein JA, Marino MC, Johnston RB, Jr., et al. Chronic granulomatous disease: report on a national registry of 368 patients. Medicine (Baltimore) 2000; 79:159–169.
Tkalcevic J, Noelli M, Phylactides M, et al. Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity. 2000; 12:201–210.
Rosenberg HF, Gallin JL. Neutrophil-specific granule deficiency includes eosinophils. Blood. 1993; 82:268–271.
Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen PM, Dustin ML. The immunological synapse: a molecular machine controlling T cell activation. Science. 1999; 285:221–227.
Sayegh MH, Turka LA. The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med. 1998, 338:1813–1820.
Fantuzzi G, Reed D, Dinarello CA. IL-12-induced interferon- is dependent on caspase-1 processing of the IL-18 precursor. J Clin Invest. 1999; 104:761–767.
Kohno K, Kataoka J, Ohtsuki T, Suemoto Y, Okamoto I, Usui M, et al. IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th 1 but not Th2 cells and exerts its effect independently of IL-12. J Immunol. 1997; 158:1541–1550.
Netea MG, Fantuzzi G, Kullberg BJ, Stuyt RJ, Pulido EJ, McIntyre RC Jr, et al. Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia. J Immunol. 2000; 164:2644–2649
Tsutui H, Kayagaki N, Kuida K, Nakano H, Hayashi N, Takeda K, et al. Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. Immunity. 1999; 11:359–367.
43. Kaufman SHE. γ/δ and other unconventional T lymphocytes: what do they see and what do they do? Proc Natl Acad Sci USA. 1996; 93:2277–2279.
Purcell SA. The CD1 family: a third lineage of antigen-presenting molecules. Adv Immunol. 1995; 59:1–98.
Porter RR. Structure and activation of the early components of complement. Fed Proc. 1977; 36:2191–6.
Ross SC, Densen P. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of Neisserial and other infections in an immune deficiency. Medicine. 1984; 243–273.
Gotze O, Muller-Eberhard HJ. The C3 activator system: an alternate pathway of complement activation. J Exp Med. 1971. 134:Suppl:90–108.
Turner MW. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today. 1996;
Schweinie JE, Ezekowitz R. Alan B., Tenner AJ, Kuhlman M, Joiner KA. Human mannose-binding protein activates the alternative complement pathway and enhances serum bactericidal activity on a mannose-rich isolate of Salmonella. J Clin Invest. 1989; 84:1821–1829.
Polotsky VY, Fischer W, Ezekowitz R. Alan B, Joiner KA. Interactions of human mannose-binding protein with lipoteichoic acids. Infect Immun. 1996; 64:380–383.
Summerfield JA, Sumiya M, Levin M, Turner MW. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. Brit Med J. 1997; 314:1229–1231.
Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999; 340:438–454.
Fattori E, Cappelletti M, Costa P, et al. Defective inflammatory response to interleukin-6-deficient mice. J Exp Med. 1994; 180:1243–1250.
Cermak J, Key MS, Bach R, Baila J, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood. 1993; 82:513–520.
Mold C, Gewurz H, DuClos TW. Regulation of complement activation by C-reactive protein. Immunopharmacology 1999; 42:23–30.
Mortensen RF, Zhong W. Regulation of phagocytic leukocyte activities by C-reactive protein. J Leukoc Biol. 2000; 67:495–500.
Wurfel MM, Kunitake ST, Lichenstein H, Kane JP, Wright ST. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a co-factor in the neutralization of LPS. J Exp Med. 1994; 180:1025–1035.
Ulevitch RJ, Tobias PS. Recognition of Gram-negative bacteria and endotoxin by the innate immune system. Curr Opin Immunol. 1999; 11:19–22.
Jack RS, Fan X, Bernheiden M, et al. Lipopolysaccharide-binding protein is required to combat a murine Gram-negative bacterial infection. Nature. 1997; 389:742–745.
Lamping N, Dettmer R. Schröder NI, et al. LPS-binding protein protects mice from septic shock caused by LPS or Gram-negative bacteria. J Clin Invest. 1998; 101:2065–2071.
Viriyakosol S, Mathison JC, Tobias PS, Kirkland TN. Structure-function analysis of CD 14 as a soluble receptor for lipopolysaccharide. J Biol Chem. 2000; 275:3144–3149
Rey Nores JE, Bensussan A, Vita N, Stelter F, Arias MA, Jones M, LeFort S, Borysiewicz LK, Ferrara P, Labeta MO. Soluble CD14 acts as a negative regulator of human T cell activation and function. Eur J Immunol. 1999; 29:265–276.
Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol. 1999; 163:1–5.
Joklik WK. “Interferons” in Fields Virology, Fields BN, Knipe DM., eds New York, NY: Raven Press, 1990.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Opal, S.M., Yap, R.L. (2003). Host Microbicidal Actions of the Innate Immune Response. In: Doughty, L.A., Linden, P. (eds) Immunology and Infectious Disease. Molecular and Cellular Biology of Critical Care Medicine, vol 3. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0245-6_1
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0245-6_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4984-6
Online ISBN: 978-1-4615-0245-6
eBook Packages: Springer Book Archive